Human umbilical cord mesenchymal stem cells attenuate cisplatin-induced acute and chronic renal injury

Experimental Biology and Medicine

Volumn 238, Issue 7, 2013, Pages 960-970

  Peng, Xiujuan ^a,b   Xu, Huitao ^a   Zhou, Ying ^a   Wang, Bingying ^a   Yan, Yongmin ^a   Zhang, Xu ^a   Wang, Mei ^a   Gao, Shuo ^a   Zhu, Wei ^a   Xu, Wenrong ^a   Qian, Hui ^a  

^a JIANGSU UNIVERSITY   (China)

^b Third People's Hospital of Mianyang City   (China)

Author keywords

acute kidney injury; epithelial mesenchymal transition; Human umbilical cord mesenchymal stem cells; renal interstitial fibrosis; transplantation

Indexed keywords

BETA ACTIN; BETA1 INTEGRIN; CD33 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; CD71 ANTIGEN; CISPLATIN; CREATININE; HERMES ANTIGEN; INTERLEUKIN 1BETA; MICROSOMAL AMINOPEPTIDASE; PROTEIN BAX; PROTEIN BCL 2; TRANSCRIPTION FACTOR SLUG; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FLOW CYTOMETRY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; KIDNEY INJURY; MESENCHYMAL STEM CELL; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING;

ACUTE KIDNEY INJURY; EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLS; RENAL INTERSTITIAL FIBROSIS; TRANSPLANTATION;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; BLOOD UREA NITROGEN; CELLS, CULTURED; CHRONIC DISEASE; CISPLATIN; COCULTURE TECHNIQUES; CREATININE; DISEASE MODELS, ANIMAL; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FIBROSIS; HUMANS; KIDNEY; MESENCHYMAL STEM CELL TRANSPLANTATION; RATS; RATS, SPRAGUE-DAWLEY; REGENERATION; UMBILICAL CORD;

EID: 84883781658     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370213497176     Document Type: Article

References (31)

1. Thadhani R,Pascual M,Bonventre JV.Acute renal failure.N Engl J Med. 1996;334:1448-60.
2. Van Berendoncks AM,Elseviers MM,Lins RL,Study Group SHARF.Outcome of acute kidney injury with different treatment options: long-term follow-up.Clin J Am Soc Nephrol. 2010;5:1755-62.
3. Lo LJ,Go AS,Chertow GM,McCulloch CE,Fan D,Ordoñez JD,Hsu CY.Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease.Kidney Int. 2009;76:893-9.
4. Tögel FE,Westenfelder C.Mesenchymal stem cells, a new therapeutic tool for AKI.Nat Rev Nephrol. 2010;6:179-83.
5. Tögel F,Hu Z,Weiss K,Isaac J,Lange C,Westenfelder C.Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms.Am J Physiol Renal Physiol. 2005;289:F31-42.
6. Morigi M,Imberti B,Zoja C,Corna D,Tomasoni S,Abbate M,Rottoli D,Angioletti S,Benigni A,Perico N,Alison M,Remuzzi G.Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure.J Am Soc Nephrol. 2004;15:1794-804.
7. Imberti B,Morigi M,Tomasoni S,Rota C,Corna D,Longaretti L,Rottoli D,Valsecchi F,Benigni A,Wang J,Abbate M,Zoja C,Remuzzi G.Insulin-like growth factor-1 sustains stem cell mediated-renal repair.J Am Soc Nephrol. 2007;18:2921-8.
8. Morigi M,Introna M,Imberti B,Corna D,Abbate M,Rota C,Rottoli D,Benigni A,Perico N,Zoja C,Rambaldi A,Remuzzi A,Remuzzi G.Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice.Stem Cells. 2008;26:2075-82.
9. Eliopoulos N,Zhao J,Bouchentouf M,Forner K,Birman E,Yuan S,Boivin MN,Martineau D.Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection.Am J Physiol Renal Physiol. 2010;299:F1288-98.
10. Yuan L,Wu MJ,Sun HY,Xiong J,Zhang Y,Liu CY,Fu LL,Liu DM,Liu HQ,Mei CL.VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin-induced acute kidney injury.Am J Physiol Renal Physiol. 2011;300:F207-18.
11. Wang HS,Hung SC,Peng ST,Huang CC,Wei HM,Guo YJ,Fu YS,Lai MC,Chen CC.Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord.Stem Cells. 2004;22:1330-7.
12. Weiss ML,Anderson C,Medicetty S,Seshareddy KB,Weiss RJ,VanderWerff I,Troyer D,McIntosh KR.Immune properties of human umbilical cord Wharton's jelly-derived cells.Stem cells. 2008;26:2865-74.
13. Lund RD,Wang S,Lu B,Girman S,Holmes T,Sauvé Y,Messina DJ,Harris IR,Kihm AJ,Harmon AM,Chin FY,Gosiewska A,Mistry SK.Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease.Stem Cells. 2007;25:602-11.
14. Chao KC,Chao KF,Fu YS,Liu SH.Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes.PLoS One. 2008;3:e1451-e1451.
15. Rachakatla RS,Pyle MM,Ayuzawa R,Edwards SM,Marini FC,Weiss ML,Tamura M,Troyer D.Combination treatment of human umbilical cord matrix stem cell-based interferon-beta gene therapy and 5-fluorouracil significantly reduces growth of metastatic human breast cancer in SCID mouse lungs.Cancer Invest. 2008;26:662-70.
16. Cao H,Qian H,Xu W,Zhu W,Zhang X,Chen Y,Wang M,Yan Y,Xie Y.Mesenchymal stem cells derived from human umbilical cord ameliorate ischemia/reperfusion-induced acute renal failure in rats.Biotechnol Lett. 2010;32:725-32.
17. Chen Y,Qian H,Zhu W,Zhang X,Yan Y,Ye S,Peng X,Li W,Xu W.Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury.Stem Cell Dev. 2011;20:103-13.
18. Qiao C,Xu W,Zhu W,Hu J,Qian H,Yin Q,Jiang R,Yan Y,Mao F,Yang H,Wang X,Chen Y.Human mesenchymal stem cells isolated from the umbilical cord.Cell Biol Int. 2008;32:8-15.
19. Ramesh G,Reeves W.TNF alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity.J Clin Invest. 2002;110:835-42.
20. Rawat S,Gray C,Johnson TS,Raftery AT,El Nahas AM,Haylor J.Apoptosis and expression of BCL-2 and BAX in cyclosporine-induced experimental renal fibrosis.Transplant Proc. 2003;35:187-8.
21. Zeisberg M,Kaluri R.The role of epithelial-to-mesenchymal transition in renal fibrosis.J Mol Med. 2004;82:175-81.
22. Venkov CD,Link AJ,Jennings JL,Plieth D,Inoue T,Nagai K,Xu C,Dimitrova YN,Rauscher FJ,Neilson EG.A proximal activator of transcription in epithelial-mesenchymal transition.J Clin Invest. 2007;117:482-91.
23. Arany I,Safirstein RL.Cisplatin nephrotoxicity.Semin Nephrol. 2003;23:460-4.
24. Matsushima H,Yonemura K,Ohishi K,Hishida A.The role of oxygen free radicals in cisplatin induced acute renal failure in rats.J Lab Clin Med. 1998;131:518-26.
25. Jiang M,Dong Z.Regulation and pathological role of p53 in cisplatin nephrotoxicity.J Pharmacol Exp Ther. 2008;327:300-7.
26. Jing XB,Cai XB,Hu H,Chen SZ,Chen BM,Cai JY.Reactive oxygen species and mitochondrial membrane potential are modulated during CDDP-induced apoptosis in EC-109 cells.Biochem Cell Biol. 2007;85:265-71.
27. Choi YJ,Baranowska-Daca E,Nguyen V,Koji T,Ballantyne CM,Sheikh-Hamad D,Suki WN,Truong LD.Mechanism of chronic obstructive uropathy: increased espression of apoptosis-promoting molecules.Kidney Int. 2000;58:1481-91.
28. Nangaku M.Mechanisms of tubulointerstitial injury in the kidney:Final common pathways to end-stage renal failure.Intern Med. 2004;43:9-17.
29. Liu Y.Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention.J Am Soc Nephrol. 2004;15:1-12.
30. Strutz FM.EMT and proteinuria as progression factors.Kidney Int. 2009;75:475-81.
31. Liu YH.New insights into epithelial-mesenchymal transition in kidney fibrosis.J Am Soc Nephrol. 2010;21:212-22.